Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Jasper Therapeutics, Inc. (AMHCU)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20
   10-K10-K10-K
Revenues   [+]2.239.2-11.1
            Revenue growth  -94.4%-452.8% 
Cost of goods sold  -53.00.0-85.4
Gross profit  55.239.274.3
            Gross margin  2507.6%100.0%-669.6%
Selling, general and administrative   [+]18.313.06.0
Research and development  35.525.616.1
Other operating expenses  51.236.873.0
EBITDA   [+]-48.8-35.8 
            EBITDA margin  -2218.1%-91.5%186.4%
Depreciation and amortization  1.00.4 
EBIT   [+]-49.8-36.2-20.7
            EBIT margin  -2262.4%-92.5%186.4%
Non-recurring items  1.40.6 
Other income (expense), net   [+]13.56.2-11.0
Pre-tax income  -37.7-30.6-31.7
Income taxes  0.00.00.0
            Tax rate  0.0%0.0%0.0%
Net income  -37.7-30.6-31.7
            Net margin  -1713.0%-78.2%285.4%
   
Basic EPS   [+]($1.03)($2.69)($5.17)
Diluted EPS   [+]($1.03)($2.69)($5.17)
   
Shares outstanding (basic)   [+]36.511.46.1
Shares outstanding (diluted)   [+]36.511.46.1
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy